Adefovir dipivoxil for the treatment of chronic hepatitis B

被引：0
|
作者：
Mutimer, D [1 ]
机构：
[1] Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England
来源：
ANTIVIRAL THERAPY | 2002年 / 7卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
6
引用
收藏
页码：L84 / L84
页数：1
相关论文
共 50 条
  • [1] Adefovir dipivoxil in the treatment of chronic hepatitis B
    Rivkin, AM
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (04) : 625 - 633
  • [2] Treatment of patients with chronic hepatitis B with adefovir dipivoxil
    Tong, MJ
    Tu, SS
    [J]. SEMINARS IN LIVER DISEASE, 2004, 24 : 37 - 44
  • [3] Adefovir dipivoxil in chronic hepatitis B infection
    Yuen, MF
    Lai, CL
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (11) : 2361 - 2367
  • [4] Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B
    Dai, Chia-Yen
    Chuang, Wan-Long
    Hsieh, Ming-Yen
    Lee, Li-Po
    Huang, Jee-Fu
    Hou, Nai-Jen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Hsieh, Ming-Yuh
    Wang, Liang-Yen
    Tsai, Jun-Fa
    Chang, Wen-Yu
    Yu, Ming-Lung
    [J]. ANTIVIRAL RESEARCH, 2007, 75 (02) : 146 - 151
  • [5] Adefovir dipivoxil (ADV) 10 mg for the treatment of chronic hepatitis B
    Chang, TT
    Lim, SG
    Hadziyannis, S
    Tassopoulos, N
    Tong, M
    Sievert, W
    Shiffman, M
    Jeffers, L
    Goodman, Z
    Wulfsohn, M
    Xiong, S
    James, C
    Fry, J
    Brosgart, C
    Marcellin, P
    [J]. GASTROENTEROLOGY, 2002, 123 (01) : 68 - 68
  • [6] Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil
    Yeon, J. E.
    Yoo, W.
    Hong, S. P.
    Chang, Y. J.
    Yu, S. K.
    Kim, J. H.
    Seo, Y. S.
    Chung, H. J.
    Moon, M. S.
    Kim, S-O
    Byun, K. S.
    Lee, C. H.
    [J]. GUT, 2006, 55 (10) : 1488 - 1495
  • [7] Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
    Marcellin, P
    Chang, T
    Lim, SG
    Tong, MJ
    Sievert, W
    Shiffman, ML
    Jeffers, L
    Goodman, Z
    Wulfsohn, MS
    Xiong, S
    Fry, J
    Brosgart, CL
    Afdhal, N
    O'Conner, C
    Andreone, P
    Cursaro, C
    Angus, P
    Vaughan, R
    Bain, V
    Gutfreund, K
    Barange, K
    Duffant, M
    Barnes, E
    Bennett, M
    Pressman, J
    Bernstein, D
    Bonino, F
    Coco, B
    Borum, M
    Schuck, S
    Bourliere, M
    Benali, S
    Boyer, N
    Castelnau, C
    Brown, R
    Scales, S
    Buggisch, P
    Peterson, J
    Cooksley, G
    MacDonald, G
    Couzigou, P
    Foucner, D
    Crawford, D
    Der, A
    Desmond, P
    Boussioutas, A
    DiBisceglie, A
    Bacon, B
    Dieterich, D
    Goldman, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09): : 808 - 816
  • [8] Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
    Hadziyannis, SJ
    Tassopoulos, NC
    Heathcote, EJ
    Chang, TT
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Lim, SG
    Goodman, Z
    Wulfsohn, MS
    Xiong, S
    Fry, J
    Brosgart, CL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09): : 800 - 807
  • [9] Resistance to adefovir dipivoxil in patients with chronic hepatitis B
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 (1): : 4 - 4
  • [10] Extended treatment with adefovir dipivoxil in patients with chronic hepatitis B virus infection
    Gilson, RJC
    Murray-Lyon, IM
    Nelson, MR
    Rice, SJ
    Tedder, RS
    Murray, A
    Jaffe, HS
    Weller, IVD
    [J]. HEPATOLOGY, 1998, 28 (04) : 491A - 491A
12345